期刊
SEMINARS IN IMMUNOLOGY
卷 22, 期 3, 页码 173-182出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.smim.2010.03.002
关键词
Dendritic cells; IL-12; Immunotherapy; Cancer; Vaccines; Cytokines; Chemokines; Chemokine receptors; Th1; CTL; NK; T-reg
类别
资金
- NIH [CA095128, CA114931, CA101944, CA121773, EA055944, CA137214, NS055140, NS40923]
Ex vivo generation and antigen loading of dendritic cells (DCs) from cancer patients helps to bypass the dysfunction of endogenous DCs. It also allows to control the process of DC maturation and to imprint in maturing DCs several functions essential for induction of effective forms of cancer immunity. Recent reports from several groups including ours demonstrate that distinct conditions of DC generation and maturation can prime DCs for preferential interaction with different (effector versus regulatory) subsets of immune cells. Moreover, differentially-generated DCs have been shown to imprint different effector mechanisms in CD4(+) and CD8(+) T cells (delivery of signal three) and to induce their different homing properties (delivery of signal four). These developments allow for selective induction of tumor-specific T cells with desirable effector functions and tumor-relevant homing properties and to direct the desirable types of immune cells to tumors. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据